Literature DB >> 20539089

Resveratrol protects against protease inhibitor-induced reactive oxygen species production, reticulum stress and lipid raft perturbation.

Olivia Touzet1, Alexandre Philips.   

Abstract

OBJECTIVE: HIV protease inhibitors have been successfully used in highly active antiretroviral therapy of HIV-1 infection, but their benefits are compromised by a number of clinically important adverse side-effects. Several studies showed that protease inhibitors induce sarco/endoplasmic reticulum stress and overproduction of reactive oxygen species (ROS), but the hierarchy of these events was never established in protease inhibitor-treated cells. Our objective was to determine whether ROS production and sarco/endoplasmic reticulum stress were co-induced by protease inhibitors in human primary skeletal myotubes and whether antioxidant treatment with resveratrol could protect against protease inhibitor-induced cellular damages. DESIGN AND METHODS: We analyzed in cultures of primary human skeletal myotubes the effects of four protease inhibitors (atazanavir, lopinavir, ritonavir and saquinavir) on ROS production (by measuring the reduction of nitro blue tetrazolium and by fluorescence microscopy using CM-H2DCFDA), on sarco/endoplasmic reticulum stress induction (by immunofluorescence and electron microscopy) and on the expression and localization at lipid rafts of Caveolin 3 and Flotillin 1, two major components of lipid rafts (by immunoblotting and biochemical experiments). Cells were co-incubated with resveratrol to assess its protective effects.
RESULTS: In myotubes, protease inhibitors increased ROS production, altered sarco/endoplasmic reticulum morphology, increased expression of C/EBP homologous protein, a sarco/endoplasmic reticulum stress marker, and decreased expression and localization at lipid rafts of Caveolin 3 and Flotillin 1. Importantly, these deleterious protease inhibitor effects were inhibited by the antioxidant resveratrol.
CONCLUSION: Our findings demonstrate a protective effect of resveratrol against protease inhibitor-induced sarco/endoplasmic reticulum stress in human myotubes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20539089     DOI: 10.1097/QAD.0b013e32833a6114

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  20 in total

Review 1.  White matter loss and oligodendrocyte dysfunction in HIV: A consequence of the infection, the antiretroviral therapy or both?

Authors:  Brigid K Jensen; Lindsay M Roth; Judith B Grinspan; Kelly L Jordan-Sciutto
Journal:  Brain Res       Date:  2019-08-20       Impact factor: 3.252

2.  Cinnamtannin B-1, a natural antioxidant that reduces the effects of H(2)O(2) on CCK-8-evoked responses in mouse pancreatic acinar cells.

Authors:  Antonio Gonzalez; Patricia Santofimia-Castaño; Ramon Rivera-Barreno; Gines M Salido
Journal:  J Physiol Biochem       Date:  2011-11-26       Impact factor: 4.158

3.  Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.

Authors:  Niels Heinz; Birgitta Ehrnström; Axel Schambach; Adrian Schwarzer; Ute Modlich; Bernhard Schiedlmeier
Journal:  Stem Cells Transl Med       Date:  2015-07-09       Impact factor: 6.940

4.  Cellular Redox Profiling Using High-content Microscopy.

Authors:  Tom Sieprath; Tobias Corne; Joke Robijns; Werner J H Koopman; Winnok H De Vos
Journal:  J Vis Exp       Date:  2017-05-14       Impact factor: 1.355

5.  Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1.

Authors:  Alonso Heredia; Charles Davis; Mohammed N Amin; Nhut M Le; Mark A Wainberg; Maureen Oliveira; Steven G Deeks; Lai-Xi Wang; Robert R Redfield
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

6.  Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones.

Authors:  Debasis Mondal; Kai Liu; Milton Hamblin; Joseph A Lasky; Krishna C Agrawal
Journal:  Ochsner J       Date:  2013

7.  Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors.

Authors:  Mahadeo A Sukhai; Swayam Prabha; Rose Hurren; Angela C Rutledge; Anna Y Lee; Shrivani Sriskanthadevan; Hong Sun; Xiaoming Wang; Marko Skrtic; Ayesh Seneviratne; Maria Cusimano; Bozhena Jhas; Marcela Gronda; Neil MacLean; Eunice E Cho; Paul A Spagnuolo; Sumaiya Sharmeen; Marinella Gebbia; Malene Urbanus; Kolja Eppert; Dilan Dissanayake; Alexia Jonet; Alexandra Dassonville-Klimpt; Xiaoming Li; Alessandro Datti; Pamela S Ohashi; Jeff Wrana; Ian Rogers; Pascal Sonnet; William Y Ellis; Seth J Corey; Connie Eaves; Mark D Minden; Jean C Y Wang; John E Dick; Corey Nislow; Guri Giaever; Aaron D Schimmer
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

8.  Targeting of the purine biosynthesis host cell pathway enhances the activity of tenofovir against sensitive and drug-resistant HIV-1.

Authors:  Alonso Heredia; Charles E Davis; Marvin S Reitz; Nhut M Le; Mark A Wainberg; James S Foulke; Lai-Xi Wang; Robert R Redfield
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

9.  Protease Inhibitors, Saquinavir and Darunavir, Inhibit Oligodendrocyte Maturation: Implications for Lysosomal Stress.

Authors:  Lindsay Festa; Lindsay M Roth; Brigid K Jensen; Jonathan D Geiger; Kelly L Jordan-Sciutto; Judith B Grinspan
Journal:  J Neuroimmune Pharmacol       Date:  2019-11-28       Impact factor: 4.147

Review 10.  Resveratrol-loaded nanomedicines for cancer applications.

Authors:  Manjusha Annaji; Ishwor Poudel; Sai H S Boddu; Robert D Arnold; Amit K Tiwari; R Jayachandra Babu
Journal:  Cancer Rep (Hoboken)       Date:  2021-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.